Lymphocyte Trafficking in the Central Nervous System

  • H. Lassmann
Part of the Topics in Neuroscience book series (TOPNEURO)


The central nervous system (CNS) is separated from the peripheral immune system by the blood-brain barrier. This tight barrier system impedes the exchange of cells and inflammatory mediators between the nervous tissue and the blood. Thus, for our understanding of the pathogenesis of brain inflammation, essential questions deal with the mechanisms of normal immune surveillance, the routes and mechanisms by which immune cells are recruited into the brain, how immune cells recognize their specific brain targets, and finally how they are cleared from established lesions during recovery. Basic principles regarding these questions have been recognized during recent years, and these will be discussed in this short review.


Major Histocompatibility Complex Experimental Autoimmune Encephalomyelitis Experimental Allergic Encephalomyelitis Inclusion Body Myositis Brain Inflammation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Wekerle H, Linington C, Lassmann H, Meyermann R (1986) Cellular immune reactivity within the CNS. Trends Neurosci 9: 271–277CrossRefGoogle Scholar
  2. 2.
    Hickey WF, Hsu BL, Kimura H (1991) T lymphocyte entry into the central nervous system in experimental allergic encephalomyelitis. J Neurosci Res 28: 254–260PubMedCrossRefGoogle Scholar
  3. 3.
    Male D, Pryce G, Rahman J (1990) Comparison of immunological properties of rat cerebral and aortic endothelium. J Neuroimmunol 30: 161–168PubMedCrossRefGoogle Scholar
  4. 4.
    Sobel RA, Mitchell ME, Fondren G (1990) Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am J Pathol 136: 1309–1316PubMedGoogle Scholar
  5. 5.
    Yednock TA, Cannon C, Fritz LC et al. (1992) Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha4-betal integrin. Nature 356:63–66PubMedCrossRefGoogle Scholar
  6. 6.
    Cannella B, Cross AH, Raine CS (1991) Adhesion-related molecules in the central nervous system. Upregulation correlates with inflammatory cell influx during relapsing autoimmune encephalomyelitis. Lab Invest 65: 23–31PubMedGoogle Scholar
  7. 7.
    Lassmann H, Rössler K, Zimprich F, Vass K (1991) Expression of adhesion molecules and histocompatibility antigens at the blood-brain barrier. Brain Pathol 1:115–123PubMedCrossRefGoogle Scholar
  8. 8.
    Schlüsener HJ, Meyermann R (1993) Intercrines in brain pathology. Expression of intercrines in a multiple sclerosis and a Creutzfeld-Jacob lesion. Acta Neuropathol (Berl) 86: 393–396CrossRefGoogle Scholar
  9. 9.
    Tani M, Ransohoff RM (1994) Do chemokines mediate inflammatory cell invasion of the central nervous system parenchyma? Brain Pathol 4:135–143PubMedCrossRefGoogle Scholar
  10. 10.
    Ransohoff RM (1997) Chemokines in neurological disease models: Correlation between chemokine expression patterns and inflammatory pathology. J Leukoc Biol 62: 645–652PubMedGoogle Scholar
  11. 11.
    Ruff M, Wahl SM, Pert CB (1985) Substance P receptor mediated chemotaxis of human monocytes. Peptide 6:107–111Google Scholar
  12. 12.
    Smith CH, Barker JN, Morris RW et al. (1993) Neuropeptides induce rapid expression of endothelial adhesion molecules and elicit granulocytic infiltration in human skin. J Immunol 151: 3274–3282PubMedGoogle Scholar
  13. 13.
    Storch MK, Fischer-Colbrie R, Smith T et al. (1996) Co-localization of secretoneurin immunoreactivity and macrophage infiltration in the lesions of experimental autoimmune encephalomyelitis. Neuroscience 71: 885–893PubMedCrossRefGoogle Scholar
  14. 14.
    Raine CS, Cannella B, Duijvestijn AM, Cross AH (1990) Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelial cell adhesion during initial stages of autoimmune demyelination. Lab Invest 63:476–489PubMedGoogle Scholar
  15. 15.
    Wisniewski HM, Lossinsky AS (1991) Structural and functional aspects of the interaction of inflammatory cells with the blood-brain barrier in experimental brain inflammation. Brain Pathol 1: 89–96PubMedCrossRefGoogle Scholar
  16. 16.
    Cross AH, Raine CS (1991) Central nervous system endothelial cell-polymorphonu-clear cell interactions during autoimmune demyelination. Am J Pathol 139:1401–1409PubMedGoogle Scholar
  17. 17.
    Vass K, Lassmann H (1990) Intrathecal application of interferon gamma: progressive appearance of MHC antigens within the rat nervous system. Am J Pathol 137: 789–800PubMedGoogle Scholar
  18. 18.
    Hickey WF, Kimura H (1988) Perivascular microglial cells of the CNS are bone marrow derived and present antigen in vivo. Science 239: 290–292PubMedCrossRefGoogle Scholar
  19. 19.
    Lassmann H, Schmied M, Vass K, Hickey WF (1993) Bone marrow derived elements and resident microglia in brain inflammation. Glia 7: 19–24PubMedCrossRefGoogle Scholar
  20. 20.
    Neumann H, Boucraut J, Hahnel C et al. (1996) Neuronal control of MHC class II inducibility in rat astrocytes and microglia. Eur J Neurosci 8: 2582–2590PubMedCrossRefGoogle Scholar
  21. 21.
    Neumann H, Cavalle A, Jenne DE, Wekerle H (1995) Induction of MHC I genes in neurons. Science 269: 549–551PubMedCrossRefGoogle Scholar
  22. 22.
    Pender MP, Nguyen KB, McCombe PA, Kerr JFR (1991) Apoptosis in the nervous system in experimental allergic encephalomyelitis. J Neurol Sci 104: 81–87PubMedCrossRefGoogle Scholar
  23. 23.
    Schmied M, Breitschopf H, Gold R et al. (1993) Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis: Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am J Pathol 143: 446–452PubMedGoogle Scholar
  24. 24.
    Zettl UW, Gold R, Hartung HP, Toyka KV (1994) Apoptotic cell death of T-lymphocytes in experimental autoimmune neuritis of the Lewis rat. Neurosci Lett 176: 75–79PubMedCrossRefGoogle Scholar
  25. 25.
    Griffith TS, Brunner T, Fletcher SM et al. (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270: 1189–1192PubMedCrossRefGoogle Scholar
  26. 26.
    Schneider C, Gold R, Dalakas MC et al. (1996) MHC class-I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: Studies in patients with polymyositis, dermatomyositis and inclusion body myositis. J Neuropathol Exp Neurol 55:1205–1209PubMedCrossRefGoogle Scholar
  27. 27.
    Gold R, Hartung HP, Lassmann H (1997) T-cell apoptosis in autoimmune diseases: Termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms. Trends Neurosci 20: 399–404PubMedCrossRefGoogle Scholar
  28. 28.
    Bauer J, Bradl M, Hickey WF et al. (1998) T cell apoptosis in inflammatory brain lesions. Destruction of T-cells does not depend on antigen recognition. Am J Pathol 153: 715–724PubMedCrossRefGoogle Scholar
  29. 29.
    Griffith TS, Ferguson TA (1997) The role of Fas L-induced apoptosis in immune privilege. Immunol Today 18: 240–244PubMedCrossRefGoogle Scholar
  30. 30.
    Weishaupt A, Gold R, Gaupp S et al. (1997) Antigen therapy eliminates T cell inflammation by apoptosis: effective treatment of experimental autoimmune neuritis with recombinant myelin protein P2. Proc Natl Acad Sci USA 94:1338–1343PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1999

Authors and Affiliations

  • H. Lassmann
    • 1
  1. 1.Institute of NeurologyUniversity of ViennaViennaAustria

Personalised recommendations